HomeCompareIMVP vs SBUX

IMVP vs SBUX: Dividend Comparison 2026

IMVP yields 8.93% · SBUX yields 2.84%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SBUX wins by $130.9K in total portfolio value· pulled ahead in Year 5
10 years
IMVP
IMVP
● Live price
8.93%
Share price
$20.11
Annual div
$1.80
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$36.1K
Annual income
$1,569.19
Full IMVP calculator →
SBUX
SBUX
● Live price
2.84%
Share price
$86.72
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$71,136.45
Full SBUX calculator →

Portfolio growth — IMVP vs SBUX

📍 SBUX pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIMVPSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IMVP + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IMVP pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMVP
Annual income on $10K today (after 15% tax)
$759.27/yr
After 10yr DRIP, annual income (after tax)
$1,333.81/yr
SBUX
Annual income on $10K today (after 15% tax)
$241.12/yr
After 10yr DRIP, annual income (after tax)
$60,465.98/yr
At 15% tax rate, SBUX beats the other by $59,132.17/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMVP + SBUX for your $10,000?

IMVP: 50%SBUX: 50%
100% SBUX50/50100% IMVP
Portfolio after 10yr
$101.6K
Annual income
$36,352.83/yr
Blended yield
35.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

IMVP
No analyst data
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+19.9% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMVP buys
0
SBUX buys
0
No recent congressional trades found for IMVP or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIMVPSBUX
Forward yield8.93%2.84%
Annual dividend / share$1.80$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$36.1K$167.0K
Annual income after 10y$1,569.19$71,136.45
Total dividends collected$12.3K$136.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: IMVP vs SBUX ($10,000, DRIP)

YearIMVP PortfolioIMVP Income/yrSBUX PortfolioSBUX Income/yrGap
1$11,593$893.26$11,121$420.68+$472.00IMVP
2$13,373$967.83$12,548$648.40+$825.00IMVP
3$15,352$1,043.35$14,440$1,013.98+$912.00IMVP
4$17,546$1,119.42$17,068$1,617.30+$478.00IMVP
5← crossover$19,970$1,195.71$20,912$2,649.52$942.00SBUX
6$22,640$1,271.86$26,875$4,499.29$4.2KSBUX
7$25,572$1,347.56$36,771$8,014.12$11.2KSBUX
8$28,785$1,422.53$54,542$15,197.11$25.8KSBUX
9$32,296$1,496.48$89,602$31,242.49$57.3KSBUX
10$36,126$1,569.19$167,011$71,136.45$130.9KSBUX

IMVP vs SBUX: Complete Analysis 2026

IMVPStock

Principal Investment Strategies Change will be effective on or about February 23, 2026 (the Effective Date).. The Fund generally will invest at least 90% of its total assets in securities that comprise the New Underlying Index, as well as American depositary receipts (ADRs) and global depositary receipts (GDRs) that represent securities in the New Underlying Index.PIN aims for broad exposure to Indian stocks, eliminating only the bottom decile that dont pass its yield and quality screens. The index starts with stocks traded on National Stock Exchange of India, and then ranks them by trailing 12-month yield and removes the bottom 10%. The index also ranks by quality, a combination of profitability (return on assets, asset turnover and accruals) and leverage ratio, and removes the bottom 10%. (Financial firms use ROA only for quality.) Stocks are market-cap-weighted, subject to some position limits. Individual positions are capped at 10% for largest stock, 9% for 2nd etc. on through the top 6 names, subject to a cap of 40% total for individual positions greater than 5%. The index is reviewed semi-annually. Note: Prior to June 24, 2019 the fund tracked the Indus India Index, which differed with respect to its screens.

Full IMVP Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this IMVP vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMVP vs SCHDIMVP vs JEPIIMVP vs OIMVP vs KOIMVP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.